Home LiteratureArticle Details
PMID: 6268807 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.

Journal of virology ·Vol. 39 ·No. 1 ·1981-07-00 ·Pages 172-84

Edson CM, Thorley-Lawson DA

Abstract

The Epstein-Barr virus (EBV)-associated membrane antigen polypeptides (350,000, 220,000, 140,000, and 85,000 daltons) are recognized by a rabbit anti-EBV serum and are present on the plasma membranes of producer cell lines, as we demonstrated previously. In this report, we show that these polypeptides are present on intact virus particles. Subcellular fractionation revealed that these antigens are distributed throughout the cell, except for the 85,000-dalton protein, which was poorly represented in the nuclear fraction. In addition, an EBV-associated protein of 160,000 daltons, which comigrates with a major component of the viral capsid, was detected in the cytoplasmic and nuclear fractions. The immunoprecipitation patterns of 13 different EBV isolates were similar, with two exceptions. First, the 350,000- and 220,000-dalton polypeptides from marmoset cell lines had slightly larger molecular sizes than the corresponding polypeptides from human cell lines. Second, B95-8 virus and B95-8-derived human and marmoset cell lines contained little of the 220,000-dalton protein; however, 883L, the human parent line of B95-8, has a normal amount of the 220,000-dalton protein. Thus, the B95-8 strain of EBV appears to be a structurally defective variant. We have not observed any variation in protein patterns associated with different EBV disease states. The 350,000-, 220,000-, and 85,000-dalton polypeptides were shown to be glycoproteins by incorporation of [3H]mannose and [3H]glucosamine and to contain N-asparagine-linked glycosyl groups by their sensitivity to tunicamycin. To simplify future work, the following nomenclature for these EBV-associated polypeptides is suggested: 350,000 (gp350), 220,000 (gp220), 160,000 (p160), 140,000 (p140), and 85,000 (gp85).

MeSH Terms
Animals Antigens, Surface/analysis Antigens, Viral/analysis Callitrichinae Cell Line Defective Viruses/immunology Glycoproteins/analysis Herpesvirus 4, Human/immunology Humans Intracellular Membranes/immunology Molecular Weight Viral Proteins/analysis Virion/immunology
Chemicals
Antigens, Surface Antigens, Viral Glycoproteins Viral Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Edson C M
Thorley-Lawson D A
References (40)
40 references, click to expand
  1. Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas.
    Int J Cancer. 1979 Sep 15;24(3):294-302 PMID: 226484
  2. Tumor initiators and promoters in the induction of Epstein-Barr virus.
    Proc Natl Acad Sci U S A. 1979 Feb;76(2):782-5 PMID: 218219
  3. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  4. Mechanisms of infection with Epstein-Barr virus. I. Viral DNA replication and formation of noninfectious virus particles in superinfected Raji cells.
    J Virol. 1976 Jul;19(1):187-94 PMID: 181594
  5. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.
    Eur J Biochem. 1974 Jul 1;46(1):83-8 PMID: 4850204
  6. Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope, demonstrated by immunoferritin labelling.
    Int J Cancer. 1971 Sep 15;8(2):222-33 PMID: 4109105
  7. A virus-free immunogen effective against Epstein-Barr virus.
    Nature. 1979 Oct 11;281(5731):486-8 PMID: 226890
  8. Tunicamycin--an inhibitor of yeast glycoprotein synthesis.
    Biochem Biophys Res Commun. 1974 May 7;58(1):287-95 PMID: 4598444
  9. MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.
    J Exp Med. 1965 May 1;121:761-70 PMID: 14278230
  10. Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids.
    Virology. 1979 Sep;97(2):477-81 PMID: 224594
  11. Immunofluorescence in cells derived from Burkitt's lymphoma.
    J Bacteriol. 1966 Mar;91(3):1248-56 PMID: 4160230
  12. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    J Natl Cancer Inst. 1974 Jul;53(1):61-5 PMID: 4365906
  13. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Virology. 1979 Apr 15;94(1):228-31 PMID: 220786
  14. Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.
    J Exp Med. 1977 Aug 1;146(2):495-508 PMID: 195004
  15. Correlation between Epstein-Barr virus membrane antigen and three large cell surface glycoproteins.
    J Virol. 1979 Dec;32(3):885-94 PMID: 92577
  16. An immunoferritin study of a Burkitt lymphoma cell line harboring EB virus particles.
    Gan. 1970 Jun;61(3):279-81 PMID: 4917014
  17. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus.
    Science. 1970 Jul 10;169(3941):188-90 PMID: 4316788
  18. Search for tumor-specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction.
    Proc Natl Acad Sci U S A. 1966 Jun;55(6):1628-35 PMID: 5336290
  19. Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.
    J Immunol. 1975 Dec;115(6):1617-24 PMID: 1102604
  20. Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.
    Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699-704 PMID: 16591407
  21. DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.
    J Virol. 1978 Nov;28(2):524-42 PMID: 214576
  22. Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space.
    Clin Exp Immunol. 1969 Nov;5(5):443-59 PMID: 4902604
  23. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.
    Proc Natl Acad Sci U S A. 1968 Jan;59(1):94-101 PMID: 5242134
  24. Activation of latent Epstein-Barr virus by antibody to human IgM.
    Nature. 1978 Nov 16;276(5685):270-2 PMID: 213727
  25. Ultraviolet inactivation of Epstein-Barr virus: effect on synthesis of virus-associated antigens.
    Int J Cancer. 1975 Jul 15;16(1):1-6 PMID: 170209
  26. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus.
    Proc Natl Acad Sci U S A. 1973 Sep;70(9):2487-91 PMID: 4354852
  27. Polypeptides of the Epstein-Barr virus membrane antigen complex.
    J Virol. 1979 Nov;32(2):458-67 PMID: 228070
  28. Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus.
    J Virol. 1976 Mar;17(3):935-49 PMID: 176452
  29. Persisting oncogenic herpesvirus induced by the tumour promotor TPA.
    Nature. 1978 Mar 23;272(5651):373-5 PMID: 204874
  30. Appearance of Epstein-Barr virus-associated antigens in infected Raji cells.
    Virology. 1971 Jul;45(1):10-21 PMID: 4329584
  31. A new tumour-derived transforming strain of Epstein-Barr virus.
    Nature. 1978 Apr 13;272(5654):629-31 PMID: 205793
  32. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Int J Cancer. 1979 Jun 15;23(6):808-17 PMID: 89099
  33. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups.
    J Natl Cancer Inst. 1969 Nov;43(5):1147-57 PMID: 5353242
  34. Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA).
    Virology. 1980 Apr 30;102(2):360-9 PMID: 6245514
  35. Preparation and properties of lymphocyte plasma membrane.
    Contemp Top Mol Immunol. 1974;3:27-56 PMID: 4611687
  36. Suppression of glycoprotein formation of Semliki Forest, influenza, and avian sarcoma virus by tunicamycin.
    J Virol. 1976 Sep;19(3):782-91 PMID: 184299
  37. Epstein-Barr virus-induced proteins. II. Analysis of surface polypeptides from EBV-producing and -superinfected cells by immunoprecipitation.
    Virology. 1980 Apr 30;102(2):401-11 PMID: 6154378
  38. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells.
    J Virol. 1979 Dec;32(3):710-6 PMID: 229261
  39. Characterization of cross-reacting antigens on the Epstein-Barr virus envelope and plasma membranes of producer cells.
    Cell. 1979 Jan;16(1):33-42 PMID: 217544
  40. Proteins of Epstein-Barr Virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus.
    J Virol. 1976 Apr;18(1):289-97 PMID: 176465
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1981-07-00
Pages
172-84
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC171276
Subset
IM
Grants
NIAID NIH HHS · 1R01-AI1-5310-03 · United States
NCI NIH HHS · 1R01-CA-28737-01 · United States
NCRR NIH HHS · 5-SO7-RR-05526-17 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com